| James Stephens, DO | |
|
3411 W Rock Creek Rd Ste 120, Norman, OK 73072-2466 | |
| (405) 759-8407 | |
| (405) 724-6482 |
| Full Name | James Stephens |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 14 Years |
| Location | 3411 W Rock Creek Rd Ste 120, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235459413 | NPI | - | NPPES |
| 200403990A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 5121 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grady Memorial Hospital | Chickasha, OK | Hospital |
| Onecore Health | Oklahoma city, OK | Hospital |
| Norman Regional | Norman, OK | Hospital |
| Duncan Regional Hospital, Inc | Duncan, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jws Medical Pllc | 5991196933 | 3 |
News Archive
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's Disease.
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
The most popular method of breast cancer detection today is X-ray mammography, which takes images of a compressed breast by low-dose ionizing radiation. However, there are several disadvantages to using X-rays for breast cancer screening, chief among them being the invasivity of radiation and the high costs, which limit their wide use and can deter women from getting them. In addition, depending on the age of the patient and tissue density, X-ray mammograms often result in false positives and negatives.
Ultrasound-guided non-surgical therapy significantly reduces pain from calcific tendonitis of the rotator cuff and restores mobility, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).
AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.
› Verified 1 days ago
| Entity Name | Grady Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750370268 PECOS PAC ID: 0648175778 Enrollment ID: O20031203000193 |
News Archive
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's Disease.
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
The most popular method of breast cancer detection today is X-ray mammography, which takes images of a compressed breast by low-dose ionizing radiation. However, there are several disadvantages to using X-rays for breast cancer screening, chief among them being the invasivity of radiation and the high costs, which limit their wide use and can deter women from getting them. In addition, depending on the age of the patient and tissue density, X-ray mammograms often result in false positives and negatives.
Ultrasound-guided non-surgical therapy significantly reduces pain from calcific tendonitis of the rotator cuff and restores mobility, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).
AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.
› Verified 1 days ago
| Entity Name | Jws Medical Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649936121 PECOS PAC ID: 5991196933 Enrollment ID: O20211229001246 |
News Archive
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's Disease.
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
The most popular method of breast cancer detection today is X-ray mammography, which takes images of a compressed breast by low-dose ionizing radiation. However, there are several disadvantages to using X-rays for breast cancer screening, chief among them being the invasivity of radiation and the high costs, which limit their wide use and can deter women from getting them. In addition, depending on the age of the patient and tissue density, X-ray mammograms often result in false positives and negatives.
Ultrasound-guided non-surgical therapy significantly reduces pain from calcific tendonitis of the rotator cuff and restores mobility, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).
AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Stephens, DO 2100 W Iowa Ave, Chickasha, OK 73018-2736 Ph: (405) 224-2100 | James Stephens, DO 3411 W Rock Creek Rd Ste 120, Norman, OK 73072-2466 Ph: (405) 759-8407 |
News Archive
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's Disease.
Mayo Clinic captured the top two prizes for Innovative Services in Health Management, one of twelve categories presented by the Edison Awards at the ceremony in Chicago.
The most popular method of breast cancer detection today is X-ray mammography, which takes images of a compressed breast by low-dose ionizing radiation. However, there are several disadvantages to using X-rays for breast cancer screening, chief among them being the invasivity of radiation and the high costs, which limit their wide use and can deter women from getting them. In addition, depending on the age of the patient and tissue density, X-ray mammograms often result in false positives and negatives.
Ultrasound-guided non-surgical therapy significantly reduces pain from calcific tendonitis of the rotator cuff and restores mobility, according to a study presented at the annual meeting of the Radiological Society of North America (RSNA).
AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.
› Verified 1 days ago